Regulations.gov document
Guidance for Industry; Immunogenicity-Related Considerations for Low Molecular Weight…
Other · FDA-2014-D-0310 · posted Feb 21, 2016
Key facts
| Document ID | FDA-2014-D-0310-0008 |
|---|---|
| Title | Guidance for Industry; Immunogenicity-Related Considerations for Low Molecular Weight Heparin |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2014-D-0310 |
| Posted | Feb 21, 2016 |
| Comment period opens | Feb 21, 2016 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: